BECN1 and small cell lung carcinoma: Overall, our study has confirmed the anti-proliferative effect of Beclin 1-targeting stapled peptides in SCLC and has elucidated two key mechanistic insights, including their distinct autosis-centric activity and macropinocytosis-mediated cellular uptake.